CHRW
67
3
FDX
54
14
MLM
57
-3
ACN
70
5
ABT
57
-5
NI
73
3
PM
58
2
FOX
57
-3
LEG
31
3
RRC
60
-3
IFF
53
2
ROK
67
5
MPC
47
3
LOW
58
2
DE
36
-2
WHR
70
4
MAT
38
-3
DUK
50
-2
STZ
58
3
FRT
48
2
CHRW
67
3
FDX
54
14
MLM
57
-3
ACN
70
5
ABT
57
-5
NI
73
3
PM
58
2
FOX
57
-3
LEG
31
3
RRC
60
-3
IFF
53
2
ROK
67
5
MPC
47
3
LOW
58
2
DE
36
-2
WHR
70
4
MAT
38
-3
DUK
50
-2
STZ
58
3
FRT
48
2
Financhill
Back

SPDR® Portfolio Corporate Bond ETF Vs. Neurogene Industry Stock Comparison

Sell
43

SPBO
SPDR® Portfolio Corporate Bond ETF

Last Price:
29.06
Seasonality Move:
0.71%
Sell
5

NGNE
Neurogene

Last Price:
40.25
Seasonality Move:
50.43%
Sell
43
SPDR® Portfolio Corporate Bond ETF (SPBO) is a Sell

Is SPDR® Portfolio Corporate Bond ETF a Buy, Sell or Hold?

  • The current SPDR® Portfolio Corporate Bond ETF [SPBO] share price is $28.97. The Score for SPBO is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • SPBO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
5
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SPBO Stock Price Chart

What is SPDR® Portfolio Corporate Bond ETF's stock price today?

  • The SPDR® Portfolio Corporate Bond ETF share price today is $28.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPBO is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $39.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

SPBO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 38.22 Sell
Chaikin Money Flow: -459514 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.06 - 29.5) Sell
Bollinger Bands (100): (29 - 29.86) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.3 Buy
Relative Strength Index (14 RSI): 39.1 Sell
Chaikin Money Flow: -346626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.29 - 61.53) Sell
Bollinger Bands (100): (34.11 - 50.51) Sell

SPBO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.12 Sell
20-day SMA: 29.21 Sell
50-day SMA: 29.62 Sell
200-day SMA: 29.09 Sell
8-day EMA: 29.12 Sell
20-day EMA: 29.23 Sell
50-day EMA: 29.41 Sell
200-day EMA: 29.17 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.39 Sell
20-day SMA: 53.17 Sell
50-day SMA: 46.66 Sell
200-day SMA: 38.93 Buy
8-day EMA: 54.03 Sell
20-day EMA: 53.18 Sell
50-day EMA: 48.36 Sell
200-day EMA: 38.47 Buy

SPDR® Portfolio Corporate Bond ETF Earnings Growth & SPBO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

SPDR® Portfolio Corporate Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):